Test Price
2,800 AED✅ Home Collection Available
SCNN1A Gene Bronchiectasis with or without Elevated Sweat Chloride Type 2 Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
✔ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified Processing.
✔ Premium Logistics: Hospital‑Grade Home Collection via ISO Certified Cold‑Chain Home Collection & VIP Mobile Phlebotomy (8 AM – 11 PM).
✔ Clinical Guidance: Telephonic Post‑Test Clinical Guidance by DHA‑licensed physicians for result interpretation.
✔ Insurance: Direct Billing Verification & Assistance via WhatsApp +971 54 548 8731.
Executive Summary: SCNN1A gene analysis by advanced NGS (Next‑Generation Sequencing) provides definitive identification of pathogenic variants linked to bronchiectasis with or without elevated sweat chloride. This DHA‑licensed test delivers 99.9% diagnostic sensitivity and includes comprehensive post‑test guidance.
Test Overview & Methodology
This Next‑Generation Sequencing (NGS) test scans the entire coding region of the SCNN1A gene to identify pathogenic variants linked to bronchiectasis with or without elevated sweat chloride. Designed for precise diagnosis, carrier screening, and family risk assessment, it combines advanced variant interpretation pipelines validated against current reference datasets.
| Feature | Our SCNN1A NGS Test | Closest Alternative |
|---|---|---|
| Precision | Full gene sequencing with CNV detection; >99.9% analytical sensitivity & specificity | Targeted mutation panels may miss novel or rare variants |
| Methodology | Illumina NovaSeq X Plus, validated ClinVar/HGMD Professional AI‑assisted annotation | Sanger sequencing of selected exons; limited coverage |
| Turnaround Time | 3–4 Weeks (expedited options available) | 6–8 weeks in many reference labs |
Physician Insight & Safety Protocols
“This test illuminates a genetic predisposition, but its true value emerges only when correlated with your personal and family history. I encourage you to view the results as a piece of your whole clinical story; please never alter a prescribed medication without thorough medical consultation.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Safety Advisory
Medication Caution
Do not discontinue any prescribed medication (including bronchodilators, mucolytics, or antibiotics) without consulting your treating physician. Genetic findings do not replace ongoing clinical management.
Exclusion Criteria & Emergency Red Flags
Exclusion Criteria
- Inability to provide valid informed consent (mandatory pre‑test genetic counselling).
- Acute febrile illness or severe respiratory distress at time of sampling – reschedule.
- Known active bleeding disorder or current anticoagulation that cannot be safely paused (consult physician).
Seek immediate emergency care if you experience:
- Sudden worsening of shortness of breath or haemoptysis.
- Signs of severe dehydration or electrolyte imbalance (confusion, profound weakness).
- High fever with purulent sputum indicating possible respiratory infection.
Patient FAQ & Clinical Guidance
1. Who should consider the SCNN1A gene test?
Individual adults and children with unexplained bronchiectasis, especially when accompanied by elevated sweat chloride levels or a family history of similar symptoms, are prime candidates. This includes those with recurrent respiratory infections, chronic cough, and nasal polyps, as well as asymptomatic relatives seeking risk clarification.
2. What does a positive SCNN1A result mean for my health?
A pathogenic variant confirms a genetic predisposition to bronchiectasis and may explain elevated sweat chloride, but it does not predict exactly when or how severely symptoms will develop. It enables personalized surveillance, early intervention, and informed family planning. Genetic counselling will clarify the specific variant’s impact and guide management with your pulmonology team.
3. Is any special preparation or fasting required before the blood draw?
No fasting is required; a simple blood sample, extracted DNA, or a drop of blood on an FTA Card can be collected, making it convenient even for paediatric or remote home collection. Genetic counselling must be completed prior to sampling, and you should continue your regular medications unless your doctor advises otherwise.
UAE Regulatory & Data Privacy Adherence
This diagnostic service operates under the strict compliance framework of Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All patient data is encrypted, access‑controlled, and processed solely for clinical reporting purposes. Clinical safety and consent protocols follow Federal Decree-Law No. 4 of 2016 on Medical Liability.
Clinical & Logistical Metadata
| Test Name | SCNN1A Gene Bronchiectasis with or without Elevated Sweat Chloride Type 2 Genetic Test (NGS) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks (expedited options available) |
| Sample Type / Matrix | Whole Blood (3‑5 mL), Extracted DNA, or Dried Blood Spot (FTA Card) – VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection available daily 8 AM‑11 PM |
| Methodology Used | Next‑Generation Sequencing (Illumina NovaSeq X Plus) with CNV detection and AI‑assisted variant annotation |
| ICD-10-CM Code | J47.9 (Bronchiectasis, unspecified) |
| LOINC Code | 84415-0 (SCNN1A gene mutation analysis in Blood or Tissue by Sequencing) |
| DHA Facility License & Laboratory Address | Facility License: 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians